| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.978 | 0.004 | 0.978 | Analgesic | 0.91 0.004 CID_10322049 | ||
| 0.938 | 0.002 | 0.938 | Analgesic, opioid | 0.772 0.003 CID_10322049 | ||
| 0.917 | 0.001 | 0.917 | Opioid agonist | 0.754 0.002 CID_10322049 | ||
| 0.912 | 0.001 | 0.912 | Opioid antagonist | 0.802 0.002 CID_10322049 | ||
| 0.892 | 0.001 | 0.892 | Opioid delta receptor agonist | 0.674 0.002 CID_10322049 | ||
| 0.877 | 0.001 | 0.877 | Opioid mu receptor antagonist | 0.745 0.002 CID_10322049 | ||
| 0.867 | 0.001 | 0.867 | Opioid delta receptor antagonist | 0.742 0.002 CID_10322049 | ||
| 0.826 | 0.001 | 0.826 | Opioid kappa receptor antagonist | 0.692 0.002 CID_10322049 | ||
| 0.798 | 0.001 | 0.798 | Opioid mu receptor agonist | 0.64 0.002 CID_10322049 | ||
| 0.715 | 0.003 | 0.715 | Antipruritic | 0.439 0.005 CID_10322049 | ||
| 0.644 | 0.001 | 0.644 | Opioid kappa receptor agonist | 0.422 0.002 CID_10322049 | ||
| 0.631 | 0.009 | 0.638 | Immunosuppressant | 0.638 0.009 CID_10322049 | CID_10322049 | |
| 0.557 | 0.037 | 0.848 | Transcription factor NF kappa B inhibitor | 0.848 0.01 CID_10322049 | CID_10322049 | |
| 0.45 | 0.002 | 0.45 | Toll-Like receptor 4 antagonist | 0.386 0.003 CID_10322049 | ||
| 0.45 | 0.004 | 0.45 | Sigma receptor antagonist | 0.052 0.033 CID_10322049 | ||
| 0.466 | 0.103 | 0.747 | Antiinflammatory | 0.747 0.023 CID_10322049 | CID_10322049 | |
| 0.339 | 0.034 | 0.398 | Psychostimulant | 0.398 0.023 CID_10322049 | CID_10322049 | |
| 0.329 | 0.035 | 0.468 | Nitric oxide antagonist | 0.468 0.018 CID_10322049 | CID_10322049 | |
| 0.298 | 0.007 | 0.298 | Toll-Like receptor antagonist | |||
| 0.328 | 0.06 | 0.378 | Spasmolytic | 0.378 0.045 CID_10322049 | CID_10322049 | |
| 0.248 | 0.029 | 0.248 | Cholinergic | |||
| 0.243 | 0.028 | 0.413 | Protein kinase stimulant | 0.413 0.007 CID_10322049 | CID_10322049 | |
| 0.222 | 0.009 | 0.222 | Antineoplastic alkaloid | 0.153 0.027 CID_10322049 | ||
| 0.252 | 0.049 | 0.252 | Anesthetic general | 0.173 0.092 CID_10322049 | ||
| 0.222 | 0.033 | 0.222 | Acetylcholine M1 receptor antagonist | |||
| 0.259 | 0.072 | 0.259 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.248 | 0.084 | 0.55 | Antioxidant | 0.55 0.015 CID_10322049 | CID_10322049 | |
| 0.219 | 0.055 | 0.392 | Hepatoprotectant | 0.392 0.014 CID_10322049 | CID_10322049 | |
| 0.176 | 0.017 | 0.176 | Breast cancer-resistant protein inhibitor | |||
| 0.189 | 0.036 | 0.189 | Acetylcholinesterase inhibitor | |||
| 0.244 | 0.092 | 0.244 | 5 Hydroxytryptamine release stimulant | 0.168 0.155 CID_10322049 | ||
| 0.314 | 0.163 | 0.498 | Apoptosis agonist | 0.498 0.075 CID_10322049 | CID_10322049 | |
| 0.149 | 0.005 | 0.149 | Nociceptin (N/OFQ) receptor antagonist | |||
| 0.253 | 0.109 | 0.253 | Caspase 3 stimulant | 0.25 0.112 CID_10322049 | ||
| 0.171 | 0.033 | 0.442 | Cyclooxygenase 3 inhibitor | 0.442 0.004 CID_10322049 | CID_10322049 | |
| 0.173 | 0.049 | 0.173 | Toll-Like receptor 9 antagonist | |||
| 0.257 | 0.139 | 0.257 | Calcium channel activator | |||
| 0.182 | 0.068 | 0.182 | Sigma receptor agonist | |||
| 0.183 | 0.077 | 0.183 | P-glycoprotein inhibitor | 0.174 0.086 CID_10322049 | ||
| 0.164 | 0.065 | 0.218 | Melanin inhibitor | 0.218 0.035 CID_10322049 | CID_10322049 | |
| 0.09 | 0.004 | 0.09 | Nociceptin (N/OFQ) receptor agonist | |||
| 0.103 | 0.019 | 0.103 | CC chemokine 5 receptor agonist | |||
| 0.204 | 0.128 | 0.204 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.101 | 0.031 | 0.119 | Na+ K+ transporting ATPase inhibitor | 0.119 0.017 CID_10322049 | CID_10322049 | |
| 0.182 | 0.113 | 0.464 | Free radical scavenger | 0.464 0.02 CID_10322049 | CID_10322049 | |
| 0.132 | 0.064 | 0.132 | Cholinergic antagonist | |||
| 0.128 | 0.064 | 0.128 | Acetylcholine antagonist | |||
| 0.076 | 0.015 | 0.076 | Prolactin release inhibitor | |||
| 0.118 | 0.063 | 0.155 | Microtubule formation inhibitor | 0.155 0.035 CID_10322049 | CID_10322049 | |
| 0.147 | 0.094 | 0.195 | Interleukin 6 antagonist | 0.195 0.044 CID_10322049 | CID_10322049 | |
| 0.115 | 0.064 | 0.115 | Estrogen antagonist | |||
| 0.273 | 0.225 | 0.287 | Caspase 9 stimulant | 0.287 0.209 CID_10322049 | CID_10322049 | |
| 0.142 | 0.094 | 0.142 | Growth hormone agonist | |||
| 0.101 | 0.054 | 0.101 | Prolactin inhibitor | |||
| 0.103 | 0.058 | 0.103 | Estrogen receptor beta antagonist | |||
| 0.135 | 0.091 | 0.135 | Adenylate cyclase stimulant | |||
| 0.087 | 0.043 | 0.087 | Alpha 2a adrenoreceptor antagonist | |||
| 0.091 | 0.055 | 0.091 | Alpha 2 adrenoreceptor antagonist | |||
| 0.085 | 0.054 | 0.193 | Antineoplastic antibiotic | 0.193 0.022 CID_10322049 | CID_10322049 | |
| 0.049 | 0.019 | 0.049 | Dopamine D5 agonist | |||
| 0.049 | 0.024 | 0.049 | Parathyroid hormone antagonist | |||
| 0.097 | 0.072 | 0.31 | Expectorant | 0.31 0.008 CID_10322049 | CID_10322049 | |
| 0.146 | 0.125 | 0.146 | Antimitotic | |||
| 0.029 | 0.009 | 0.029 | Dopamine D1 agonist | 0.027 0.01 CID_10322049 | ||
| 0.076 | 0.06 | 0.076 | Acetylcholine nicotinic antagonist | |||
| 0.176 | 0.16 | 0.287 | DNA synthesis inhibitor | 0.287 0.048 CID_10322049 | CID_10322049 | |
| 0.019 | 0.007 | 0.019 | NMDA receptor phencyclidine site antagonist | |||
| 0.034 | 0.023 | 0.034 | Estrogen receptor beta agonist | |||
| 0.023 | 0.014 | 0.023 | Vitamin D receptor antagonist | 0.022 0.014 CID_10322049 | ||
| 0.02 | 0.013 | 0.02 | Progesterone receptor B antagonist | |||
| 0.035 | 0.053 | 0.05 | Microtubule stabilization | 0.05 0.028 CID_10322049 | CID_10322049 | |
| 0.116 | 0.145 | 0.194 | Interferon gamma antagonist | 0.194 0.043 CID_10322049 | CID_10322049 | |
| 0.013 | 0.062 | 0.033 | Protein 30S ribosomal subunit inhibitor | 0.033 0.012 CID_10322049 | CID_10322049 | |
| 0.159 | 0.22 | 0.418 | Immunomodulator | 0.418 0.039 CID_10322049 | CID_10322049 | |
| 0.027 | 0.091 | 0.084 | Protein 50S ribosomal subunit inhibitor | 0.084 0.018 CID_10322049 | CID_10322049 | |
| 0.097 | 0.162 | 0.511 | Angiogenesis stimulant | 0.511 0.011 CID_10322049 | CID_10322049 | |
| 0.118 | 0.191 | 0.4 | Immunostimulant | 0.4 0.049 CID_10322049 | CID_10322049 | |
| 0.078 | 0.154 | 0.176 | Lipid peroxidase inhibitor | 0.176 0.052 CID_10322049 | CID_10322049 | |
| 0.164 | 0.243 | 0.327 | Apoptosis antagonist | 0.327 0.068 CID_10322049 | CID_10322049 | |
| 0.06 | 0.145 | 0.114 | Transcription factor NF kappa B stimulant | 0.114 0.028 CID_10322049 | CID_10322049 | |
| 0.035 | 0.121 | 0.049 | Factor III inhibitor | 0.049 0.038 CID_10322049 | CID_10322049 | |
| 0.041 | 0.151 | 0.057 | Lipocortins synthesis agonist | 0.057 0.043 CID_10322049 | CID_10322049 | |
| 0.02 | 0.131 | 0.057 | Antibiotic Aminoglycoside-like | 0.057 0.01 CID_10322049 | CID_10322049 | |
| 0.053 | 0.188 | 0.092 | Thioredoxin inhibitor | 0.092 0.059 CID_10322049 | CID_10322049 | |
| 0.02 | 0.186 | 0.052 | Alpha-mannosidase inhibitor | 0.052 0.039 CID_10322049 | CID_10322049 | |
| 0.05 | 0.217 | 0.202 | Amylase inhibitor | 0.202 0.043 CID_10322049 | CID_10322049 | |
| 0.119 | 0.309 | 0.324 | Peptidyltransferase inhibitor | 0.324 0.017 CID_10322049 | CID_10322049 | |
| 0.096 | 0.291 | 0.496 | Hypoglycemic | 0.496 0.015 CID_10322049 | CID_10322049 | |
| 0.07 | 0.279 | 0.326 | NOS3 expression enhancer | 0.326 0.014 CID_10322049 | CID_10322049 | |
| 0.077 | 0.307 | 0.206 | Vasodilator | 0.206 0.1 CID_10322049 | CID_10322049 | |
| 0.065 | 0.295 | 0.213 | Interleukin agonist | 0.213 0.109 CID_10322049 | CID_10322049 | |
| 0.097 | 0.353 | 0.426 | Antithrombotic | 0.426 0.043 CID_10322049 | CID_10322049 | |
| 0.029 | 0.303 | 0.114 | Topoisomerase II inhibitor | 0.114 0.072 CID_10322049 | CID_10322049 | |
| 0.1 | 0.397 | 0.524 | Antibacterial | 0.524 0.034 CID_10322049 | CID_10322049 | |
| 0.055 | 0.354 | 0.265 | Platelet adhesion inhibitor | 0.265 0.044 CID_10322049 | CID_10322049 | |
| 0.021 | 0.332 | 0.11 | Topoisomerase I inhibitor | 0.11 0.062 CID_10322049 | CID_10322049 | |
| 0.017 | 0.367 | 0.054 | Glucose-6-phosphate translocase inhibitor | 0.054 0.032 CID_10322049 | CID_10322049 | |
| 0.103 | 0.463 | 0.319 | Interleukin 2 agonist | 0.319 0.061 CID_10322049 | CID_10322049 | |
| 0.05 | 0.411 | 0.27 | Insulin secretagoues | 0.27 0.016 CID_10322049 | CID_10322049 | |
| 0.034 | 0.413 | 0.121 | Cell wall synthesis inhibitor | 0.121 0.098 CID_10322049 | CID_10322049 | |
| 0.015 | 0.553 | 0.081 | ATPase (Vacuolar H+) inhibitor | 0.081 0.075 CID_10322049 | CID_10322049 | |
| 0.028 | 0.592 | 0.213 | Tumour necrosis factor alpha release inhibitor | 0.213 0.098 CID_10322049 | CID_10322049 | |
| 0.013 | 0.672 | 0.153 | Platelet antagonist | 0.153 0.141 CID_10322049 | CID_10322049 | |
| 0.012 | 0.678 | 0.157 | Thrombolytic | 0.157 0.077 CID_10322049 | CID_10322049 | |
| 0.004 | 0.721 | 0.2 | Selectin antagonist | 0.2 0.011 CID_10322049 | CID_10322049 | |
| 0.013 | 0.846 | 0.479 | Cyclophilin D inhibitor | 0.479 0.057 CID_10322049 | CID_10322049 | |
| 0.007 | 0.859 | 0.1 | Cell adhesion inhibitor | 0.1 0.09 CID_10322049 | CID_10322049 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |